CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-29 | CLARK IAN T Director | Option exercise · Restricted stock units | −1,878 | 0 | ||
| 2020-05-29 | MARAGANORE JOHN Director | Option exercise | +1,878 | 30,172 | ||
| 2020-05-29 | MARAGANORE JOHN Director | Option exercise · Restricted stock units | −1,878 | 0 | ||
| 2020-05-29 | Ho Maykin Director | Option exercise | +1,878 | 3,278 | ||
| 2020-05-29 | Ho Maykin Director | Option exercise · Restricted stock units | −1,878 | 0 | ||
| 2020-05-28 | Schenkein David P Director | Grant or award · Stock options (right to buy) | +8,096 | 8,096 | ||
| 2020-05-28 | Schenkein David P Director | Grant or award · Restricted stock units | +1,686 | 1,686 | ||
| 2020-05-28 | Scadden David Director | Grant or award · Stock options (right to buy) | +8,096 | 8,096 | ||
| 2020-05-28 | Scadden David Director | Grant or award · Restricted stock units | +1,686 | 1,686 | ||
| 2020-05-28 | Clancy Paul J Director | Grant or award · Stock options (right to buy) | +8,096 | 8,096 | ||
| 2020-05-28 | Clancy Paul J Director | Grant or award · Restricted stock units | +1,686 | 1,686 | ||
| 2020-05-28 | Foster-Cheek Kaye I Director | Grant or award · Stock options (right to buy) | +8,096 | 8,096 | ||
| 2020-05-28 | Foster-Cheek Kaye I Director | Grant or award · Restricted stock units | +1,686 | 1,686 | ||
| 2020-05-28 | CLARK IAN T Director | Grant or award · Stock options (right to buy) | +8,096 | 8,096 | ||
| 2020-05-28 | CLARK IAN T Director | Grant or award · Restricted stock units | +1,686 | 1,686 | ||
| 2020-05-28 | MARAGANORE JOHN Director | Grant or award · Stock options (right to buy) | +8,096 | 8,096 | ||
| 2020-05-28 | MARAGANORE JOHN Director | Grant or award · Restricted stock units | +1,686 | 1,686 | ||
| 2020-05-28 | Ho Maykin Director | Grant or award · Stock options (right to buy) | +8,096 | 8,096 | ||
| 2020-05-28 | Ho Maykin Director | Grant or award · Restricted stock units | +1,686 | 1,686 | ||
| 2020-05-20 | Bowden Christopher Chief Medical Officer | Option exercise | +3,583 | $35.16 | $126K | 11,889 |
Page 46 of 48 · 941 trades